Hemovent

About:

Hemovent is an emerging medical device company that has developed disruptive technology.

Twitter/X: hemovent

Top Investors: KfW, TechVision Fund, NRW.BANK, MIG Capital, Sagona Capital, Inc.

Description:

Based in Aachen, Germany, Hemovent is a privately held medical technology company that is developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Hemovent was founded by serial entrepreneur, Christof Lenz and Oliver Marseille, inventors of the company’s proprietary platform. It is the goal of the company to develop an innovative solution, with precision and craftsmanship, that will aide patients with lung and heart function while allowing them to be mobile.

Total Funding Amount:

$13.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Aachen, Nordrhein-Westfalen, Germany

Founded Date:

2013-01-01

Contact Email:

info(AT)hemovent.com

Founders:

Christof Lenz, Oliver Marseille

Number of Employees:

1-10

Last Funding Date:

2019-02-14

IPO Status:

Private

Industries: